Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

334 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Interleukin-2 receptor antibody versus antithymocyte globulin as part of quadruple induction therapy after orthotopic liver transplantation: a randomized study.
Langrehr JM, Guckelberger O, Nüssler N, Radtke A, Lemmens HP, Jonas S, Lohmann R, Tullius S, Steinmüller T, Raakow R, Neumann U, Knoop M, Bechstein WO, Neuhaus P. Langrehr JM, et al. Transplant Proc. 1996 Dec;28(6):3204. Transplant Proc. 1996. PMID: 8962241 Clinical Trial. No abstract available.
Distribution of lymphocyte subtypes in liver transplant recipients.
Rayes N, Bechstein WO, Volk HP, Tullius SG, Nüssler N, Naumann U, Jonas S, Neuhaus R, Serke S, Neuhaus P. Rayes N, et al. Among authors: tullius sg. Transplant Proc. 1997 Feb-Mar;29(1-2):501-2. doi: 10.1016/s0041-1345(96)00235-7. Transplant Proc. 1997. PMID: 9123103 No abstract available.
De novo malignancies after liver transplantation using tacrolimus-based protocols or cyclosporine-based quadruple immunosuppression with an interleukin-2 receptor antibody or antithymocyte globulin.
Jonas S, Rayes N, Neumann U, Neuhaus R, Bechstein WO, Guckelberger O, Tullius SG, Serke S, Neuhaus P. Jonas S, et al. Among authors: tullius sg. Cancer. 1997 Sep 15;80(6):1141-50. doi: 10.1002/(sici)1097-0142(19970915)80:6<1141::aid-cncr18>3.0.co;2-8. Cancer. 1997. PMID: 9305716 Clinical Trial.
334 results